Biohaven Pharmaceuticals
Stuart Murray is an accomplished professional in the field of computational biology with extensive expertise in systems biology and informatics. Currently serving as Executive Director of Computational Biology at Biohaven since August 2022, Stuart previously held significant positions at Agios Pharmaceuticals, including Director of the Mitochondrial Biology Group and Research Fellow in Informatics, where the focus was on genetically inherited mitochondrial disorders and pipeline development for rare genetic diseases. Earlier experience includes roles at Pfizer as Principal Research Scientist and Senior Research Scientist in systems biology analytics, as well as a postdoctoral position at Albert Einstein Medical Center. Stuart earned a Ph.D. in Molecular Biology/Biochemistry from Newcastle University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices